FindTrial
Sign In

Application of preoperative thoracic paravertebral block in thoracoscopic-laparoscopic esophagectomy

Application of preoperative thoracic paravertebral block in thoracoscopic-laparoscopic esophagectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043458
Enrollment
Unknown
Registered
2021-02-19
Start date
2021-02-19
Completion date
Unknown
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

experimental group:preoperative multi-injection thoracic paravertebral block via the intrathoracic approach
contral group:preoperative multi-injection thoracic paravertebral block via the intrathoracic approach with normal saline

Sponsors

Ningbo Medical Center Li Huili hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients with stage 1-2 esophageal cancer who plan to undergo thoracoscopic-laparoscopic esophagectomy.

Exclusion criteria

Exclusion criteria: Patients with coagulation dysfunction, severe cardiopulmonary dysfunction, neuropsychiatric diseases and local anesthetic allergy.

Design outcomes

Primary

MeasureTime frame
stress indicator;—

Countries

China

Contacts

Public ContactLihong Hu

Ningbo Medical Center Li Huili hospital

hlh_2000@163.com+86 13586584415

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026